Targeting Fcgamma receptors in the treatment of multiple sclerosis.

Schaefer, B.; Pellkofer, H.; Breithaupt, C.; Huber, R.; Jacob, U.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Targeting Fcgamma receptors in the treatment of multiple sclerosis.

MPS-Authors

/persons/resource/persons78613

Schaefer, B.
Huber, Robert / Structure Research, Max Planck Institute of Biochemistry, Max Planck Society;
Ullrich, Axel / Molecular Biology, Max Planck Institute of Biochemistry, Max Planck Society;

/persons/resource/persons78142

Huber, R.
Huber, Robert / Structure Research, Max Planck Institute of Biochemistry, Max Planck Society;

/persons/resource/persons78156

Jacob, U.
Huber, Robert / Structure Research, Max Planck Institute of Biochemistry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Schaefer, B., Pellkofer, H., Breithaupt, C., Huber, R., & Jacob, U. (2006). Targeting Fcgamma receptors in the treatment of multiple sclerosis. Clinical Immunology, 119(Suppl. Suppl. S), S115-S116.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0010-6459-5

Abstract

There is no abstract available